Search research articles
Contact Us
Filters
Showing results (261-270 of 301) with videos related to
Page
of 31
Sort By:
Cancer Research
|
June 11, 1998
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)
D J Loftus, P Squarcina, M B Nielsen, et al.
Experimental Hematology
|
December 1, 1995
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
S Siena, M Di Nicola, M Bregni, et al.
Cancer Research
|
August 1, 1995
Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas
S Salvi, F Segalla, S Rao, et al.
The Journal of Experimental Medicine
|
October 1, 1993
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone
M Sensi, S Salvi, C Castelli, et al.
Cancer Research
|
April 15, 1991
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression
I Martìn-Padura, R Mortarini, D Lauri, et al.
Cancer Gene Therapy
|
August 11, 2001
Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy
M Rodolfo, E M Catò, S Soldati, et al.
The American Journal of Pathology
|
December 1, 1992
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma
N Jonjic, I Martìn-Padura, T Pollicino, et al.
Annals of Surgical Oncology
|
January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanoma
M Vaglini, F Belli, M Santinami, et al.
The Journal of Clinical Investigation
|
September 1, 1992
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma
P Nisticò, R Mortarini, L B De Monte, et al.
International Journal of Cancer
|
May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2
C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.
Page
of 31
Search research articles
Search
Showing results (261-270 of 301) with videos related to
Sort By:
Page
of 31
Cancer Research
|
June 11, 1998
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)
D J Loftus, P Squarcina, M B Nielsen, et al.
Experimental Hematology
|
December 1, 1995
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
S Siena, M Di Nicola, M Bregni, et al.
Cancer Research
|
August 1, 1995
Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas
S Salvi, F Segalla, S Rao, et al.
The Journal of Experimental Medicine
|
October 1, 1993
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone
M Sensi, S Salvi, C Castelli, et al.
Cancer Research
|
April 15, 1991
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression
I Martìn-Padura, R Mortarini, D Lauri, et al.
Cancer Gene Therapy
|
August 11, 2001
Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy
M Rodolfo, E M Catò, S Soldati, et al.
The American Journal of Pathology
|
December 1, 1992
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma
N Jonjic, I Martìn-Padura, T Pollicino, et al.
Annals of Surgical Oncology
|
January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanoma
M Vaglini, F Belli, M Santinami, et al.
The Journal of Clinical Investigation
|
September 1, 1992
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma
P Nisticò, R Mortarini, L B De Monte, et al.
International Journal of Cancer
|
May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2
C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.
Page
of 31